Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 5, 2019 Off

Guided Therapeutics Reports New Progress with Chinese FDA and Increased Sales Forecast from Shandong Medical Device Technology Company

By BusinessWire

NORCROSS, Ga.–(BUSINESS WIRE)–#cervicalcancer–Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its…

June 5, 2019 Off

Riffyn Enters Multi-Year Contract with Novozymes for R&D Data Analytics

By BusinessWire

OAKLAND, Calif.–(BUSINESS WIRE)–Riffyn, a leading provider of cloud-based scientific process design and data analytics, announces a multi-year partnership with world-leading…

June 5, 2019 Off

AscellaHealth Supports Migraine and Headache Awareness Month, Offers High-Touch Specialty Pharmacy Solutions, Improves Outcomes, Lowers Costs

By BusinessWire

June is time to raise awareness and spread the message about benefits of specialty drugs, such as Botox, to relieve…

June 5, 2019 Off

Devonian Announces the Filing of a New Patent Application Related to Use of Thylakoids as Delivery System for Cannabinoïds and Other Liposoluble Molecules

By BusinessWire

QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation“) (TSXv: GSD), a clinical stage biopharmaceutical corporation, today announced that the…

June 5, 2019 Off

Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer

By BusinessWire

BOSTON–(BUSINESS WIRE)–$GMDA–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the appointment of Tracey Lodie,…

June 5, 2019 Off

Omeros Corporation Announces Assignment of Rapporteurs for European Marketing Authorization Application for Narsoplimab for Treatment of HSCT-TMA

By BusinessWire

– Preparations Continue for Submission of BLA in the U.S. and MAA in Europe – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER)…

June 5, 2019 Off

T1D Exchange and DreaMed Diabetes Formalize Partnership to Optimize Insulin Treatment Plans in Clinics

By BusinessWire

Type 1 diabetes decision support technology analyzes patient data from variety of devices to determine insulin delivery recommendations for maintaining…

June 5, 2019 Off

Progenity Strengthens Executive Team with the Addition of Eric d’Esparbes as Chief Financial Officer

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company, today announced the hire of Eric d’Esparbes as Senior Vice President…

June 5, 2019 Off

Aimmune to Participate in the Goldman Sachs 40th Annual Healthcare Conference

By BusinessWire

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of…

June 5, 2019 Off

New Virta Health Results Show Sustained Type 2 Diabetes Reversal at Two Years and Continued Reduction of Insulin

By BusinessWire

Results show exciting promise for reducing dependence on medications and alleviation of the massive cost burden for people living with…

Posts pagination

Previous 1 … 5,801 5,802 5,803 … 6,283 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

January 24, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine